197 related articles for article (PubMed ID: 38169047)
21. Combined radiomics of primary tumour and bone metastasis improve the prediction of EGFR mutation status and response to EGFR-TKI therapy for NSCLC.
Cheng Y; Wang H; Yuan W; Wang H; Zhu Y; Chen H; Jiang W
Phys Med; 2023 Dec; 116():103177. PubMed ID: 38000098
[TBL] [Abstract][Full Text] [Related]
22. Radiomics for the prediction of EGFR mutation subtypes in non-small cell lung cancer.
Li S; Ding C; Zhang H; Song J; Wu L
Med Phys; 2019 Oct; 46(10):4545-4552. PubMed ID: 31376283
[TBL] [Abstract][Full Text] [Related]
23. Peritumoural MRI radiomics signature of brain metastases can predict epidermal growth factor receptor mutation status in lung adenocarcinoma.
Huang Z; Tu X; Yu T; Zhan Z; Lin Q; Huang X
Clin Radiol; 2024 Feb; 79(2):e305-e316. PubMed ID: 38000953
[TBL] [Abstract][Full Text] [Related]
24. Using contrast-enhanced CT and non-contrast-enhanced CT to predict EGFR mutation status in NSCLC patients-a radiomics nomogram analysis.
Yang X; Liu M; Ren Y; Chen H; Yu P; Wang S; Zhang R; Dai H; Wang C
Eur Radiol; 2022 Apr; 32(4):2693-2703. PubMed ID: 34807270
[TBL] [Abstract][Full Text] [Related]
25. CT-based nomogram for early identification of T790M resistance in metastatic non-small cell lung cancer before first-line epidermal growth factor receptor-tyrosine kinase inhibitors therapy.
Li Y; Lv X; Wang Y; Xu Z; Lv Y; Hou D
Eur Radiol Exp; 2023 Nov; 7(1):64. PubMed ID: 37914925
[TBL] [Abstract][Full Text] [Related]
26. Using Radiomics to Differentiate Brain Metastases From Lung Cancer Versus Breast Cancer, Including Predicting Epidermal Growth Factor Receptor and human Epidermal Growth Factor Receptor 2 Status.
Shi J; Chen H; Wang X; Cao R; Chen Y; Cheng Y; Pang Z; Huang C
J Comput Assist Tomogr; 2023 Nov-Dec 01; 47(6):924-933. PubMed ID: 37948368
[TBL] [Abstract][Full Text] [Related]
27. Clinical characteristics and MRI based radiomics nomograms can predict iPFS and short-term efficacy of third-generation EGFR-TKI in EGFR-mutated lung adenocarcinoma with brain metastases.
Qi H; Hou Y; Zheng Z; Zheng M; Qiao Q; Wang Z; Sun X; Xing L
BMC Cancer; 2024 Mar; 24(1):362. PubMed ID: 38515096
[TBL] [Abstract][Full Text] [Related]
28. CT-based non-invasive identification of the most common gene mutation status in patients with non-small cell lung cancer.
Chen Z; Gao S; Ding C; Luo T; Xu J; Xu S; Li S
Med Phys; 2024 Mar; 51(3):1872-1882. PubMed ID: 37706584
[TBL] [Abstract][Full Text] [Related]
29. Next-Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Algorithms.
Shiri I; Maleki H; Hajianfar G; Abdollahi H; Ashrafinia S; Hatt M; Zaidi H; Oveisi M; Rahmim A
Mol Imaging Biol; 2020 Aug; 22(4):1132-1148. PubMed ID: 32185618
[TBL] [Abstract][Full Text] [Related]
30. MRI features and whole-lesion apparent diffusion coefficient histogram analysis of brain metastasis from non-small cell lung cancer for differentiating epidermal growth factor receptor mutation status.
Zheng Y; Huang WJ; Han N; Jiang YL; Ma LY; Zhang J
Clin Radiol; 2023 Mar; 78(3):e243-e250. PubMed ID: 36577557
[TBL] [Abstract][Full Text] [Related]
31. Contrast-enhanced T1-weighted image radiomics of brain metastases may predict EGFR mutation status in primary lung cancer.
Ahn SJ; Kwon H; Yang JJ; Park M; Cha YJ; Suh SH; Lee JM
Sci Rep; 2020 Jun; 10(1):8905. PubMed ID: 32483122
[TBL] [Abstract][Full Text] [Related]
32. Development and externally validate MRI-based nomogram to assess EGFR and T790M mutations in patients with metastatic lung adenocarcinoma.
Fan Y; Dong Y; Wang H; Wang H; Sun X; Wang X; Zhao P; Luo Y; Jiang X
Eur Radiol; 2022 Oct; 32(10):6739-6751. PubMed ID: 35729427
[TBL] [Abstract][Full Text] [Related]
33. Deep Learning With an Attention Mechanism for Differentiating the Origin of Brain Metastasis Using MR images.
Jiao T; Li F; Cui Y; Wang X; Li B; Shi F; Xia Y; Zhou Q; Zeng Q
J Magn Reson Imaging; 2023 Nov; 58(5):1624-1635. PubMed ID: 36965182
[TBL] [Abstract][Full Text] [Related]
34. Radiomics for prediction of response to EGFR-TKI based on metastasis/brain parenchyma (M/BP)-interface.
Fan Y; Zhao Z; Wang X; Ai H; Yang C; Luo Y; Jiang X
Radiol Med; 2022 Dec; 127(12):1342-1354. PubMed ID: 36284030
[TBL] [Abstract][Full Text] [Related]
35. A radiomics-based deep learning approach to predict progression free-survival after tyrosine kinase inhibitor therapy in non-small cell lung cancer.
Lu CF; Liao CY; Chao HS; Chiu HY; Wang TW; Lee Y; Chen JR; Shiao TH; Chen YM; Wu YT
Cancer Imaging; 2023 Jan; 23(1):9. PubMed ID: 36670497
[TBL] [Abstract][Full Text] [Related]
36. Multisequence MRI-based radiomics nomogram for early prediction of osimertinib resistance in patients with non-small cell lung cancer brain metastases.
Lv X; Li Y; Xu X; Zheng Z; Li F; Fang K; Wang Y; Wang B; Hou D
Eur J Radiol Open; 2023 Dec; 11():100521. PubMed ID: 37692549
[TBL] [Abstract][Full Text] [Related]
37. Development and validation of MRI-based radiomics signatures as new markers for preoperative assessment of EGFR mutation and subtypes from bone metastases.
Fan Y; Dong Y; Sun X; Wang H; Zhao P; Wang H; Jiang X
BMC Cancer; 2022 Aug; 22(1):889. PubMed ID: 35964032
[TBL] [Abstract][Full Text] [Related]
38. Multisequence MRI-based radiomics analysis for early prediction of the risk of T790M resistance in new brain metastases.
Lv X; Li Y; Wang B; Wang Y; Pan Y; Li C; Hou D
Quant Imaging Med Surg; 2023 Dec; 13(12):8599-8610. PubMed ID: 38106277
[TBL] [Abstract][Full Text] [Related]
39. Identification of predictors for brain metastasis in newly diagnosed non-small cell lung cancer: a single-center cohort study.
Park S; Lee SM; Ahn Y; Kim M; Suh CH; Do KH; Seo JB
Eur Radiol; 2022 Feb; 32(2):990-1001. PubMed ID: 34378076
[TBL] [Abstract][Full Text] [Related]
40. Predicting survival after radiosurgery in patients with lung cancer brain metastases using deep learning of radiomics and EGFR status.
Liao CY; Lee CC; Yang HC; Chen CJ; Chung WY; Wu HM; Guo WY; Liu RS; Lu CF
Phys Eng Sci Med; 2023 Jun; 46(2):585-596. PubMed ID: 36857023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
